Multidimensional nanofibrous hydrogels integrated triculture system for advanced myocardial regeneration.
Kim D., Kim YH., Lee G., Lee EC., Bhang SH., Lee K.
Animal Study on Cardiovascular Disease, published in Biofabrication (2025) — summary generated from the PubMed abstract.
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Animal Study
- Journal
- Biofabrication (2025)
- Country
- England
- Reported sample size
- —
- Source database
- PubMed
- PMID
- 39657319
- DOI
- 10.1088/1758-5090/ad9cc3
- Citations
- 6
Abstract (original English)
Myocardial infarction (MI) remains a leading cause of mortality worldwide, posing a significant challenge to healthcare systems. The limited regenerative capacity of cardiac tissue following MI results in chronic cardiac dysfunction, highlighting the urgent need for innovative therapeutic strategies. In this study, we explored the application of a multidimensional nanofibrous hydrogel for myocardial regeneration. We developed a composite hydrogel system by integrating fibrin, polycaprolactone (PCL), and alginate. In this system, fibrin supported cell proliferation and significantly enhanced angiogenesis when combined with human umbilical vein endothelial cells (HUVECs). PCL contributed to the alignment of encapsulated cells, improving their organization within the scaffold. Adipose-derived stem cells (ADSCs) were encapsulated within the hydrogel for their versatile regenerative potential, while C2C12 cells were incorporated for their ability to form muscle tissue. Additionally, the inclusion of alginate not only enhanced the mechanical properties of the hydrogel to better match the biomechanical demands of cardiac tissue but also played a critical role in reducing the immune response, thereby improving the system's biocompatibility. This study presents an advanced platform for myocardial regeneration using a nanofibrous hydrogel system designed to meet the dual requirements of
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • This is preclinical work; animal or laboratory results cannot be applied to humans.
Evidence level
Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.
Related research
- Level ASystematic ReviewEurope PMC
Factor XII-A New Therapeutic Target? A Systematic Review
Systematic Review on Cardiovascular Disease, Neuroinflammation, published in Int J Mol Sci (2026) — summary generated from the PubMed abstract.
- 2026
Int J Mol Sci1 citations - Level AMeta-analysisEurope PMC
Can cell-based therapies bridge the gap between research and reality in the treatment of myocarditis? A systematic review and meta-analysis
Meta-analysis on Cardiovascular Disease, published in Regen Ther (2026) — summary generated from the PubMed abstract.
- 2026
Regen Ther - Level AMeta-analysisEurope PMC
Efficacy and safety of stem cell therapy for myocardial infarction and heart failure: an updated systematic review and meta-analysis of randomized controlled trials
Meta-analysis with a reported sample of 3345 on Cardiovascular Disease, Stroke Research, published in Syst Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3345
Syst Rev - Level AMeta-analysisEurope PMC
Orally derived mesenchymal stem cells in the treatment of vascular diseases: a systematic review and meta-analysis
Meta-analysis on Cardiovascular Disease, published in Sci Rep (2026) — summary generated from the PubMed abstract.
- 2026
Sci Rep - Level ASystematic ReviewEurope PMC
From Preservation to Repair: A Systematic Review of Therapeutic Organ Rehabilitation During Normothermic Ex Vivo Machine Perfusion
Systematic Review with a reported sample of 12 on Cardiovascular Disease, Immune Modulation, published in Transplant Direct (2026) — summary generated from the PubMed abstract.
- 2026
- n = 12
Transplant Direct - Level AMeta-analysisEurope PMC
Safety and Efficacy of Transendocardial Stem Cells Therapy in Chronic Ischemic Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Meta-analysis on Cardiovascular Disease, Stroke Research, published in Curr Cardiol Rev (2025) — summary generated from the PubMed abstract.
- 2025
Curr Cardiol Rev